Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
- 23 April 2008
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 60 (12) , 1371-1382
- https://doi.org/10.1016/j.addr.2008.04.009
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome CarriersBioconjugate Chemistry, 2007
- PET Imaging of Soluble Yttrium-86-Labeled Carbon Nanotubes in MicePLOS ONE, 2007
- Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationGenes & Development, 2007
- Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular NormalizationPLOS ONE, 2007
- 213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal ModelClinical Cancer Research, 2006
- Treatment of Neuroblastoma Meningeal Carcinomatosis with Intrathecal Application of α-Emitting Atomic Nanogenerators Targeting Disialo-Ganglioside GD2Clinical Cancer Research, 2004
- Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclidesNuclear Medicine and Biology, 2004
- Comparison of 225actinium chelates: tissue distribution and radiotoxicityNuclear Medicine and Biology, 1999
- The Influence of EDTMP-Concentration on the Biodistribution of Radio-Lanthanides and 225-Ac in Tumor-Bearing MiceNuclear Medicine and Biology, 1997
- An Ion-exchange Study of Possible Hybridized 5f Bonding in the Actinides1Journal of the American Chemical Society, 1954